deuterium has been researched along with levodopa in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vries, JA; Fremouw-Ottevangers, DC; Muskiet, FA; Nagel, GT; Wolthers, BG | 1 |
| Cheng, BY; Collins, MA; Pronger, D; Ung-Chhun, N | 1 |
| Hayashi, T; Nakane, A; Naruse, H; Takesada, M; Yamazaki, K | 1 |
| Bailey, BA; Boulton, AA; Durden, DA; Yu, PH | 1 |
| Edwards, DJ; Rizk, M | 1 |
| Axelsson, J; Bengtsson, E; Bergström, M; Långström, B; Razifar, P; Schneider, H | 1 |
| Malmlöf, T; Schilström, B; Svensson, TH | 1 |
| Alken, RG; Feltmann, K; Konradsson-Geuken, Å; Malmlöf, T; Schilström, B; Schneider, F; Svensson, TH | 1 |
1 trial(s) available for deuterium and levodopa
| Article | Year |
|---|---|
[Metabolic changes in aromatic amino acids and monoamines in infantile autism and development of new treatment related to the finding].
Topics: 5-Hydroxytryptophan; Amino Acids; Autistic Disorder; Biogenic Monoamines; Biopterins; Carbon Isotopes; Child; Child, Preschool; Clinical Trials as Topic; Deuterium; Double-Blind Method; Humans; Levodopa; Phenylalanine; Tryptophan | 1989 |
7 other study(ies) available for deuterium and levodopa
| Article | Year |
|---|---|
Determination of 3-methoxy-4-hydroxyphenylpyruvic acid, 3,4-dihydroxyphenylethylene glycol, and 3,4-dihydroxyphenylmandelic acid in urine by mass fragmentography, with use of deuterium-labeled internal standards.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Catechols; Child; Child, Preschool; Deuterium; Dopamine; Ethylene Glycols; Gas Chromatography-Mass Spectrometry; Humans; Infant; Infant, Newborn; Levodopa; Mandelic Acids; Methoxyhydroxyphenylglycol; Middle Aged; Neuroblastoma; Parkinson Disease; Phenylpyruvic Acids; Pheochromocytoma; Reference Standards; Reference Values; Shock, Cardiogenic | 1978 |
Brain and plasma tetrahydroisoquinolines in rats: effects of chronic ethanol intake and diet.
Topics: Alcohol Drinking; Animal Feed; Animals; Brain; Chromatography, Gas; Corpus Striatum; Deuterium; Diet; Hypothalamus; Isoquinolines; Levodopa; Male; Mass Spectrometry; Rats; Rats, Inbred Strains; Serotonin; Time Factors | 1990 |
Stereospecific deuterium substitution at the alpha-carbon position of dopamine and its effect on oxidative deamination catalyzed by MAO-A and MAO-B from different tissues.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aldehydes; Animals; Blood Platelets; Chromatography, High Pressure Liquid; Deamination; Decarboxylation; Deuterium; Dopamine; Female; Humans; Kinetics; Levodopa; Liver; Male; Monoamine Oxidase; Oxidation-Reduction; Parkinson Disease; Placenta; Pregnancy; Rats; Rats, Inbred Strains; Stereoisomerism | 1986 |
Conversion of 3, 4-dihydroxyphenylalanine and deuterated 3, 4-dihydroxyphenylalanine to alcoholic metabolites of catecholamines in rat brain.
Topics: 3-Methoxy-4-hydroxyphenylethanol; Animals; Brain; Deuterium; Dopamine; Levodopa; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Phenylethyl Alcohol; Rats | 1981 |
A new application of pre-normalized principal component analysis for improvement of image quality and clinical diagnosis in human brain PET studies--clinical brain studies using [11C]-GR205171, [11C]-L-deuterium-deprenyl, [11C]-5-Hydroxy-L-Tryptophan, [11
Topics: Antiemetics; Brain; Brain Mapping; Carbon Radioisotopes; Deuterium; Humans; Image Processing, Computer-Assisted; Levodopa; Piperidines; Positron-Emission Tomography; Selegiline; Tetrazoles | 2006 |
Altered behavioural and neurochemical profile of L-DOPA following deuterium substitutions in the molecule.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain Chemistry; Carbidopa; Deuterium; Dopamine; Dopamine Agents; Levodopa; Male; Microdialysis; Motor Activity; Rats; Rats, Wistar; Time Factors | 2008 |
Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor.
Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Behavior, Animal; Brain; Deuterium; Disease Models, Animal; Dopamine; Forelimb; Levodopa; Male; Microdialysis; Monoamine Oxidase Inhibitors; Motor Activity; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Selegiline; Tyrosine 3-Monooxygenase | 2015 |